Lab Handling
GHK-Cu Handling: Reconstitution, Storage and Half-Life
How to reconstitute 50 mg and 100 mg GHK-Cu vials, whether it needs refrigeration, what its stability study showed, and why half-life claims are unreliable.
BEHIND THE ARTICLES
Jesse Brooks
Areas of expertise: Peptide lead discovery & screening, structural modification & stability optimization, pharmacodynamics & mechanism of action
Published articles
Peptide Profiles
GH Peptide Blends: Sermorelin, Tesamorelin and Ipamorelin
What sermorelin/ipamorelin and tesamorelin/CJC-1295/ipamorelin blends contain, how to calculate each component, molar ratios and how blends are tested.
Comparisons
Cagrilintide With Retatrutide or Tirzepatide
Cagrilintide acts on amylin and calcitonin receptors, not incretin receptors. Why it is paired with GLP-1 agonists, what CagriSema showed, and blend handling.
Lab Handling
Reconstituting and Storing BPC-157 in the Lab
How to reconstitute BPC-157, concentration tables for 5-20 mg vials, whether it needs refrigeration, and which parts of its sequence limit solution stability.
Research Reviews
Tirzepatide Half-Life: About Five Days, and Why
Tirzepatide's half-life is about 5 days, from a population PK model of 19 pooled studies. How albumin binding produces it and what it means for study design.
Comparisons
Thymosin Alpha-1 vs Beta-4 and the 17-23 Fragment
Thymosin alpha-1 and beta-4 are unrelated peptides that share only a historical name. How they differ, and how TB-500's 17-23 fragment relates to beta-4.
Comparisons
Tesamorelin vs Retatrutide, Tirzepatide and MOTS-c
Tesamorelin works through the GH axis; incretin peptides through GIP, GLP-1 and glucagon receptors; MOTS-c through AMPK. Four different mechanisms compared.
Comparisons
Tesamorelin vs HGH and IGF-1 LR3: Three Levels of the Axis
Tesamorelin stimulates the pituitary, HGH is the hormone itself, IGF-1 LR3 acts downstream. How the three differ in feedback, size and research use.
Comparisons
Tesamorelin vs CJC-1295: Two Ways to Stabilise GHRH
Tesamorelin keeps all 44 GHRH residues with an N-terminal cap; CJC-1295 shortens to 1-29 and substitutes four residues. How the two strategies compare.
Peptide Profiles
What Is Survodutide? Dual GLP-1 and Glucagon Agonist
Survodutide (BI 456906) is a dual glucagon and GLP-1 receptor agonist peptide. Its receptor design, trial literature and laboratory handling.
Peptide Profiles
What Is Mazdutide? An Oxyntomodulin-Based Dual Agonist
Mazdutide (IBI362, LY3305677) is a GLP-1 and glucagon receptor dual agonist built on an oxyntomodulin scaffold. Its trials and lab handling.
Comparisons
SS-31 vs MOTS-c: Targeting Mitochondria Two Ways
SS-31 accumulates in mitochondria and binds cardiolipin; MOTS-c is encoded by mitochondrial DNA. Opposite relationships to the same organelle.